Supply Chain

Biopharma manufacturers must reduce risk in their complex supply chains and establish effective monitoring and control systems.

Biopharma are looking to reduce risk, increase performance, and optimize productivity in raw material development.

An expert discusses how companies should be preparing to meet the requirements of the Drug Supply Chain Security Act, which requires phase-in of requirements to prevent counterfeiting.

PharmaChk, a portable device being developed to detect substandard medicines, receives $2-million grant.

Biopharma manufacturers must reduce the risk in their complex supply chains

FDA's Secure Supply Chain Pilot Program, RX-360, and other industry efforts advance actions to secure the drug supply chain.

The EXCiPACT Certification Scheme ensures patient safety through supplier quality while minimising the audit burden and overall costs for assessing the excipient supply chain.

Regulators and industry leaders take on the task of securing the drug supply chain.

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China&s Food and Drug Administration's shortened serialization deadline.

Equipment solutions for printing and verifying codes and combining serialization with aggregation and checkweighing were shown at Interpack 2014.

The Flexi-Cap features a first-opening indication as an anticounterfeiting solution.

New identifiers and tracking requirements aim to block illegitimate products.

EDQM has launched a database, Know-X, which collates reports on counterfeit/falsified medical products that have been detected in Council of Europe member states.

New identifiers and tracking requirements aim to block illegitimate products.

Vetter launches new serialization process to support track-and-trace efforts.

In order to ensure a safe drug supply chain, governments have implemented both legislated and voluntary programs designed to address problem areas.

Thirteen companies are accepted for participation in the supply chain program.

Recent regulatory initiatives designed to secure the global pharmaceutical supply chain will directly impact the global supply chain and API manufacturers.

PCI discusses the challenges and benefits of serialization in light of the new US track-and-trace legislation.

Industry experts discuss challenges in managing the cold chain.

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

The Drug Quality and Security Act creates national standards for serialization of drug products to protect against counterfeiting.

Temperature-sensitive pharmaceuticals and biologics depend on a variety of services and technologies to establish, maintain, and verify proper storage and transport conditions.

New weapons in the anticounterfeiting arsenal include authentication and labeling technologies.

New FDA supply chain policies aim to strengthen inspection and oversight processes.